Summary
77.36 -0.09(-0.12%)05/10/2024
Healthequity Inc (HQY)
Healthequity Inc (HQY)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.46 | 1.96 | 1.57 | 3.83 | 18.83 | 49.38 | 14.88 | 356.96 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 80.43 | |
| Open | 79.63 | |
| High | 80.78 | |
| Low | 78.98 | |
| Volume | 409,574 | |
| Change | 1.16 | |
| Change % | 1.46 | |
| Avg Volume (20 Days) | 376,425 | |
| Volume/Avg Volume (20 Days) Ratio | 1.09 | |
| 52 Week Range | 53.15 - 84.49 | |
| Price vs 52 Week High | -4.81% | |
| Price vs 52 Week Low | 51.32% | |
| Range | 1.00 | |
| Gap Up/Down | -0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 6,673 | |
| EBIDTA | 281,212,000 | |
| PE Ratio | 121.0156 | |
| PEG Ratio | 2.2902 | |
| WallStreet Target Price | 100.15 | |
| Book Value | 23.6280 | |
| Earnings Per Share | 0.6400 | |
| EPS Estimate Current Quarter | 0.5600 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 2.1900 | |
| EPS Estimate Next Year | 2.8300 | |
| Diluted EPS (TTM) | 0.6400 | |
| Revenues | ||
| Profit Marging | 0.0557 | |
| Operating Marging (TTM) | 0.1569 | |
| Return on asset (TTM) | 0.0256 | |
| Return on equity (TTM) | 0.0284 | |
| Revenue TTM | 999,587,008 | |
| Revenue per share TTM | 11.6820 | |
| Quarterly Revenue Growth (YOY) | 0.1220 | |
| Quarterly Earnings Growth (YOY) | -0.9600 | |
| Gross Profit (TTM) | 490,091,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 121.0156 | |
| Forward PE | 42.3729 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 3.3813 | |
| Revenue Enterprise Value | 7.4133 | |
| EBITDA Enterprise Value | 26.1316 | |
| Shares | ||
| Shares Outstanding | 86,158,600 | |
| Shares Float | 84,493,185 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.04 | |
| Insider (%) | 2.22 | |
| Institutions (%) | 105.49 | |
05/07 09:00 EST - GlobeNewsWire
HealthEquity Sets Date to Announce First Quarter Results
DRAPER, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, June 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, June 3, 2024, at 4:30 p.m.
HealthEquity Sets Date to Announce First Quarter Results
DRAPER, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, June 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, June 3, 2024, at 4:30 p.m.
04/24 10:51 EST - Zacks Investment Research
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
04/23 14:45 EST - Zacks Investment Research
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
03/20 12:36 EST - Zacks Investment Research
HealthEquity (HQY) Q4 Earnings Surpass Estimates, Margins Up
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the fourth quarter of fiscal 2024.
HealthEquity (HQY) Q4 Earnings Surpass Estimates, Margins Up
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the fourth quarter of fiscal 2024.
03/19 19:01 EST - Zacks Investment Research
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics
The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics
The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
03/19 18:16 EST - Zacks Investment Research
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.37 per share a year ago.
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.37 per share a year ago.
03/19 11:16 EST - Zacks Investment Research
Here's Why You Should Retain HealthEquity (HQY) Stock Now
HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
Here's Why You Should Retain HealthEquity (HQY) Stock Now
HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
03/18 10:56 EST - Zacks Investment Research
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
03/14 10:16 EST - Zacks Investment Research
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q4 Earnings
Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q4 Earnings
Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
03/14 09:40 EST - Zacks Investment Research
Should You Buy HealthEquity (HQY) Ahead of Earnings?
HealthEquity (HQY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should You Buy HealthEquity (HQY) Ahead of Earnings?
HealthEquity (HQY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
03/12 11:00 EST - Zacks Investment Research
HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth
HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth
HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
03/01 10:56 EST - Zacks Investment Research
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
02/27 13:11 EST - Zacks Investment Research
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again
HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again
HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
02/27 09:51 EST - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
02/12 11:31 EST - Zacks Investment Research
Here's Why You Should Add HealthEquity (HQY) to Your Portfolio
HealthEquity's (HQY) strength in HSA raises optimism about the stock.
Here's Why You Should Add HealthEquity (HQY) to Your Portfolio
HealthEquity's (HQY) strength in HSA raises optimism about the stock.
02/09 11:36 EST - Zacks Investment Research
3 Medical Services Stocks to Buy Amid Industry Headwinds
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.
3 Medical Services Stocks to Buy Amid Industry Headwinds
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.
01/26 10:16 EST - Zacks Investment Research
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?
HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?
HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
01/24 10:46 EST - Zacks Investment Research
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
01/17 12:46 EST - Zacks Investment Research
ELV or HQY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY). But which of these two companies is the best option for those looking for undervalued stocks?
ELV or HQY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY). But which of these two companies is the best option for those looking for undervalued stocks?
01/08 13:32 EST - Zacks Investment Research
HealthEquity (HQY) Upgraded to Buy: Here's What You Should Know
HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HealthEquity (HQY) Upgraded to Buy: Here's What You Should Know
HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).